Correction to Lancet Glob Health 2016; 4: e633–41 ((2016) 4(9) (e633–41)(S2214109X16301425)(10.1016/S2214-109X(16)30142-5));Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial

The Lancet Global Health

Volumn 4, Issue 9, 2016, Pages e633-e641

  Do, Nga T T ^a   Ta, Ngan T D ^c   Tran, Ninh T H ^c   Than, Hung M ^c   Vu, Bich T N ^a   Hoang, Long B ^a   van Doorn, H Rogier ^a,e   Vu, Dung T V ^a   Cals, Jochen W L ^d   Chandna, Arjun ^a   Lubell, Yoel ^e,f   Nadjm, Behzad ^a,e   Thwaites, Guy ^b,e   Wolbers, Marcel ^b,e   Nguyen, Kinh V ^c   Wertheim, Heiman F L ^a,e,g  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b National Hospital for Tropical Diseases ^*  (Viet Nam)

^c NATIONAL HOSPITAL FOR TROPICAL DISEASES   (Viet Nam)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLARY BLOOD; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; POINT OF CARE TESTING; PRESCHOOL CHILD; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; TELEPHONE INTERVIEW; VIETNAMESE; YOUNG ADULT; ACUTE DISEASE; CLINICAL TRIAL; INAPPROPRIATE PRESCRIBING; INFANT; POINT OF CARE SYSTEM; PREVENTION AND CONTROL; UTILIZATION; VIET NAM;

ACUTE DISEASE; ADOLESCENT; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INFANT; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PRIMARY HEALTH CARE; RESPIRATORY TRACT INFECTIONS; VIETNAM;

EID: 84993934762     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(16)30340-0     Document Type: Erratum

References (30)

1. 1 Alsan, M, Schoemaker, L, Eggleston, K, Kammili, N, Kolli, P, Bhattacharya, J, Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis. Lancet Infect Dis 15 (2015), 1203–1210.
2. 2 Song, JH, Jung, SI, Ko, KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48 (2004), 2101–2107.
3. 3 Nguyen, KV, Thi Do, NT, Chandna, A, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health, 13, 2013, 1158.
4. 4 World Health Organization's strategy to contain resistance to antimicrobial drugs. Rev Panam Salud Publica 10 (2001), 284–294 (in Spanish).
5. 5 Nga do, TT, Chuc, NT, Hoa, NP, et al. Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study. BMC Pharmacol Toxicol, 15, 2014, 6.
6. 6 Larsson, M, Falkenberg, T, Dardashti, A, et al. Overprescribing of antibiotics to children in rural Vietnam. Scand J Infect Dis 37 (2005), 442–448.
7. 7 Nguyen, QH, Nguyen, TK, Ho, D, Larsson, M, Eriksson, B, Lundborg, CS, Unnecessary antibiotic use for mild acute respiratory infections during 28-day follow-up of 823 children under five in rural Vietnam. Trans R Soc Trop Med Hyg 105 (2011), 628–636.
8. 8 Whaley, LE, Businger, AC, Dempsey, PP, Linder, JA, Visit complexity, diagnostic uncertainty, and antibiotic prescribing for acute cough in primary care: a retrospective study. BMC Fam Pract, 14, 2013, 120.
9. 9 Simon, L, Gauvin, F, Amre, DK, Saint-Louis, P, Lacroix, J, Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39 (2004), 206–217.
10. 10 Lubell, Y BS, Dunachie, S, Tanganuchitcharnchai, A, et al. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia. BMC Infect Dis, 2015 DOI:10.1186/s12879-015-1272-6 published online Nov 11.
11. 11 Aabenhus, R, Jensen, JU, Jorgensen, KJ, Hrobjartsson, A, Bjerrum, L, Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev, 11, 2014 CD010130.
12. 12 Little, P, Stuart, B, Francis, N, et al. Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 382 (2013), 1175–1182.
13. 13 Doig, GS, Simpson, F, Randomization and allocation concealment: a practical guide for researchers. J Crit Care 20 (2005), 187–191.
14. 14 Andreeva, E, Melbye, H, Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomized clinical trial with C-reactive protein testing in the intervention group. BMC Fam Pract, 15, 2014, 80.
15. 15 Cals, JW, Butler, CC, Hopstaken, RM, Hood, K, Dinant, GJ, Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ, 338, 2009, b1374.
16. 16 Segal, I, Ehrlichman, M, Urbach, J, Bar-Meir, M, Use of time from fever onset improves the diagnostic accuracy of C-reactive protein in identifying bacterial infections. Arch Dis Child 99 (2014), 974–978.
17. 17 Cals, JW, Chappin, FH, Hopstaken, RM, et al. C-reactive protein point-of-care testing for lower respiratory tract infections: a qualitative evaluation of experiences by GPs. Fam Pract 27 (2010), 212–218.
18. 18 Liu, YC, Huang, WK, Huang, TS, Kunin, CM, Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use. J Clin Epidemiol 52 (1999), 539–545.
19. 19 Wilson, G, Badarudeen, S, Godwin, A, Antibiotic screening of urine culture as a useful quality audit. J Infect Dev Ctries 5 (2011), 299–302.
20. 20 Cals, JW, Schot, MJ, de Jong, SA, Dinant, GJ, Hopstaken, RM, Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med 8 (2010), 124–133.
21. 21 Melbye, H, Aaraas, I, Fleten, N, Kolstrup, N, Mikalsen, JI, The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults. Tidsskr Nor Llaegeforen 115 (1995), 1610–1615 (in Norweigian).
22. 22 Diederichsen, HZ, Skamling, M, Diederichsen, A, et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Prim Health Care 18 (2000), 39–43.
23. 23 Landis, JR, Koch, GG, The measurement of observer agreement for categorical data. Biometrics 33 (1977), 159–174.
24. 24 Hoa, NQ, Trung, NV, Larsson, M, et al. Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study. BMC Infect Dis, 10, 2010, 85.
25. 25 Briel, M, Schuetz, P, Mueller, B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 168 (2008), 2000–2007.
26. 26 Burkhardt, O, Ewig, S, Haagen, U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 36 (2010), 601–607.
27. 27 Meili, M, Kutz, A, Briel, M, et al. Infection biomarkers in primary care patients with acute respiratory tract infections—comparison of Procalcitonin and C-reactive protein. BMC Pulm Med, 16, 2016, 43.
28. 28 Lubell, Y, Blacksell, SD, Dunachie, S, et al. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia. BMC Infect Dis, 15, 2015, 511.
29. 29 Phommasone, K, Althaus, T, Souvanthong, P, et al. Accuracy of commercially available c-reactive protein rapid tests in the context of undifferentiated fevers in rural Laos. BMC Infect Dis, 16, 2016, 61.
30. 30 Bastiaens, GJ, Bousema, T, Leslie, T, Scale-up of malaria rapid diagnostic tests and artemisinin-based combination therapy: challenges and perspectives in sub-Saharan Africa. PLoS Med, 11, 2014, e1001590.